As diabetes care continues to be a significant focus, new treatments are arising. Retatrutide, Tirzepatide, and Semaglutide represent a noteworthy advancement in GLP-1 receptor agonist medications. While all https://socialexpresions.com/story7781681/the-new-drug-vs-tirzepatid-vs-semaglutide-a-comparative-comparison